NCT00511277View on ClinicalTrials.gov

Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

April 30, 2011

Conditions
Schizophrenia
Interventions
DRUG

Seroquel®

dosage form: oral, dosage: 300-800mg/d, frequency: twice daily

Trial Locations (1)

Unknown

Department of Psychiatry and Psychotherapy, GEORG-AUGUST-UNIVERSITY GÖTTINGEN, Göttingen

All Listed Sponsors
collaborator

University of Göttingen

OTHER

lead

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

OTHER

NCT00511277 - Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study | Biotech Hunter | Biotech Hunter